Filing Flows › Kestra Medical Technologies (KMTS) › Q1 FY27 › vs Q4 FY26
Kestra Medical Technologies (KMTS) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Kestra Medical Technologies's revenue rose $2.3M (+8%) from $28.6M in Q4 FY26 to $31.0M in Q1 FY27.
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart draws each line against Q4 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $31.0M | $28.6M | $2.3M | +8% |
| Net loss | $44.1M | $38.8M | $5.3M | +14% |
| Costs & expenses | $75.1M | $68.2M | $6.9M | +10% |
| Operating costs | $68.6M | $68.0M | $646K | +1% |
| Interest & other, net | $6.4M | −$701K | $7.1M | — |
| Income tax | $50K | $192K | −$142K | -74% |
| Cost of revenue | $13.5M | $13.0M | $517K | +4% |
| Research & development | $6.8M | $5.6M | $1.2M | +21% |
| SG&A | $48.4M | $49.4M | −$1.0M | -2% |
| Operating cash sources | $44.5M | $31.3M | $13.1M | +42% |
| Depreciation | $2.7M | $2.3M | $339K | +15% |
| Share-based compensation | $9.5M | $10.3M | −$787K | -8% |
| Cash used in operations | $32.3M | $18.7M | $13.6M | +73% |
| Net loss absorbed | $44.1M | $38.8M | $5.3M | +14% |
| Working capital & other | $389K | −$7.5M | $7.9M | — |
Questions
How much did Kestra Medical Technologies's revenue grow quarter over quarter in Q1 FY27?
Kestra Medical Technologies's revenue rose $2.3M (+8%) from $28.6M in Q4 FY26 to $31.0M in Q1 FY27.